Reduced expression of STOP/MAP6 in mice leads to cognitive deficits

Schizophrenia Bulletin

Volumn 39, Issue 5, 2013, Pages 969-978

  Volle, Julien ^a,e   Brocard, Jacques ^c,d   Saoud, Mohamed ^a,b,e   Gory Faure, Sylvie ^c,d   Brunelin, Jérôme ^a,b,e   Andrieux, Annie ^c,d   Suaud Chagny, Marie Françoise ^a,b,e  

^a UNIVERSITÉ DE LYON   (France)

^b CENTRE HOSPITALIER LE VINATIER   (France)

^c INSERM   (France)

^d CEA GRENOBLE   (France)

^e UNIVERSITÉ LYON 1   (France)

Author keywords

animal model; behavioral phenotype; gene x environment interaction; microtubule; neurodevelopment; schizophrenia

Indexed keywords

AMPHETAMINE; MAP6 PROTEIN; MEMBRANE PROTEIN; PSYCHOSTIMULANT AGENT; STABLE TUBULE ONLY POLYPEPTIDE; UNCLASSIFIED DRUG;

ABNORMAL BEHAVIOR; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; GENE DOSAGE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; LEARNING; LOCOMOTION; MATERNAL DEPRIVATION; MENTAL DISEASE; MODULATION; MOUSE; NONHUMAN; PERINATAL STRESS; PHENOTYPE; POSITIVE SYNDROME; PREPULSE INHIBITION; PRIORITY JOURNAL; SOCIAL INTERACTION; SPATIAL ANALYSIS; STRESS; WILD TYPE; WORKING MEMORY;

ANIMAL MODEL; BEHAVIORAL PHENOTYPE; GENE X ENVIRONMENT INTERACTION; MICROTUBULE; NEURODEVELOPMENT; SCHIZOPHRENIA;

ANIMALS; BEHAVIOR, ANIMAL; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; GENE-ENVIRONMENT INTERACTION; HETEROZYGOTE; LOCOMOTION; MALE; MATERNAL DEPRIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROTUBULE-ASSOCIATED PROTEINS; PHENOTYPE; SCHIZOPHRENIA;

EID: 84883480526     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbs113     Document Type: Article

References (43)

1. Brandon NJ, Sawa A. Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat Rev Neurosci. 2011;12:707-722
2. Penzes P, Cahill ME, Jones KA, VanLeeuwen JE, Woolfrey KM. Dendritic spine pathology in neuropsychiatric disorders. Nat Neurosci. 2011;14:285-293
3. Martins-De-Souza D, Dias-Neto E, Schmitt A, et al. Proteome analysis of schizophrenia brain tissue. World J Biol Psychiatry. 2010;11:110-120
4. Choi KH, Zepp ME, Higgs BW, Weickert CS, Webster MJ. Expression profiles of schizophrenia susceptibility genes during human prefrontal cortical development. J Psychiatry Neurosci. 2009;34:450-458
5. Burmeister M, McInnis MG, Zöllner S. Psychiatric genetics: Progress amid controversy. Nat Rev Genet. 2008;9:527-540
6. van Os J, Kenis G, Rutten BP. The environment and schizophrenia. Nature. 2010;468:203-212
7. Brun P, Bégou M, Andrieux A, et al. Dopaminergic transmission in STOP null mice. J Neurochem. 2005;94:63-73
8. Bégou M, Brun P, Bertrand JB, et al. Post-pubertal emergence of alterations in locomotor activity in STOP null mice. Synapse. 2007;61:689-697
9. Andrieux A, Salin PA, Vernet M, et al. The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders. Genes Dev. 2002;16:2350-2364
10. Bégou M, Volle J, Bertrand JB, et al. The stop null mice model for schizophrenia displays [corrected] cognitive and social deficits partly alleviated by neuroleptics. Neuroscience. 2008;157:29-39
11. Delotterie D, Ruiz G, Brocard J, et al. Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice. Psychopharmacology. 2010;208:131-141
12. Powell KJ, Hori SE, Leslie R, et al. Cognitive impairments in the STOP null mouse model of schizophrenia. Behav Neurosci. 2007;121:826-835
13. Fradley RL, O'Meara GF, Newman RJ, Andrieux A, Job D, Reynolds DS. STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating. Behav Brain Res. 2005;163:257-264
14. Fournet V, Jany M, Fabre V, et al. The deletion of the microtubule-associated STOP protein affects the serotonergic mouse brain network. J Neurochem. 2010;115: 1579-1594
15. Bouvrais-Veret C, Weiss S, Hanoun N, et al. Microtubuleassociated STOP protein deletion triggers restricted changes in dopaminergic neurotransmission. J Neurochem. 2008;104: 745-756
16. Brenner E, Sonnewald U, Schweitzer A, Andrieux A, Nehlig A. Hypoglutamatergic activity in the STOP knockout mouse: A potential model for chronic untreated schizophrenia. Journal of neuroscience research. 2007;85:3487-3493
17. Bouvrais-Veret C, Weiss S, Andrieux A, et al. Sustained increase of alpha7 nicotinic receptors and choline-induced improvement of learning deficit in STOP knock-out mice. Neuropharmacology. 2007;52:1691-1700
18. Andrieux A, Salin P, Schweitzer A, et al. Microtubule stabilizer ameliorates synaptic function and behavior in a mouse model for schizophrenia. Biol Psychiatry. 2006; 60:1224-1230
19. Bhardwaj SK, Baharnoori M, Sharif-Askari B, Kamath A, Williams S, Srivastava LK. Behavioral characterization of dysbindin-1 deficient sandy mice. Behav Brain Res. 2009;197:435-441
20. Babovic D, O'Tuathaigh CM, O'Connor AM, et al. Phenotypic characterization of cognition and social behavior in mice with heterozygous versus homozygous deletion of catechol-O-methyltransferase. Neuroscience. 2008;155:1021-1029
21. O'Tuathaigh CM, Babovic D, O'Sullivan GJ, et al. Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1. Neuroscience. 2007;147:18-27
22. Kato T, Kasai A, Mizuno M, et al. Phenotypic characterization of transgenic mice overexpressing neuregulin-1. PLoS ONE. 2010;5:e14185
23. Eastwood SL, Lyon L, George L, Andrieux A, Job D, Harrison PJ. Altered expression of synaptic protein mRNAs in STOP) MAP6) mutant mice. J Psychopharmacol. 2007;21:635-644
24. Galiano MR, Bosc C, Schweitzer A, Andrieux A, Job D, Hallak ME. Astrocytes and oligodendrocytes express different STOP protein isoforms. J Neurosci Res. 2004; 78:329-337
25. Merenlender-Wagner A, Pikman R, Giladi E, Andrieux A, Gozes I. NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse-A microtubule-deficient model of schizophrenia. Peptides. 2010;31:1368-1373
26. Lipska BK, Weinberger DR. To model a psychiatric disorder in animals: Schizophrenia as a reality test. Neuropsychopharmacology. 2000;23:223-239
27. Benardais K, Kasem B, Couegnas A, et al. Loss of STOP protein impairs peripheral olfactory neurogenesis. PLoS ONE. 2010;5:e12753
28. Bosc C, Cronk JD, Pirollet F, et al. Cloning, expression, and properties of the microtubule-stabilizing protein STOP. Proc Natl Acad Sci USA. 1996;93:2125-2130
29. Guillaud L, Bosc C, Fourest-Lieuvin A, et al. STOP proteins are responsible for the high degree of microtubule stabilization observed in neuronal cells. J Cell Biol. 1998;142:167-179
30. Talbot K, Cho DS, Ong WY, et al. Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin. Hum Mol Genet. 2006;15:3041-3054
31. Burdick KE, Lencz T, Funke B, et al. Genetic variation in DTNBP1 influences general cognitive ability. Hum Mol Genet. 2006;15:1563-1568
32. Fallgatter AJ, Herrmann MJ, Hohoff C, et al. DTNBP1) dysbindin) gene variants modulate prefrontal brain function in healthy individuals. Neuropsychopharmacology. 2006;31:2002-2010
33. Papaleo F, Lipska BK, Weinberger DR. Mouse models of genetic effects on cognition: Relevance to schizophrenia. Neuropharmacology. 2012;62:1204-1220
34. Schloss P, Lau T. STOP - in the Name of Mood: Microtubule-associated proteins in mood and cognition. J Neurochem. 2012;121:1-3
35. Lewis CM, Levinson DF, Wise LH, et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet. 2003;73:34-48
36. Shimizu H, Iwayama Y, Yamada K, et al. Genetic and expression analyses of the STOP (MAP6) gene in schizophrenia. Schizophr Res. 2006;84:244-252
37. Thompson AD, Bartholomeusz C, Yung AR. Social cognition deficits and the 'ultra high risk' for psychosis population: A review of literature. Early Interv Psychiatry. 2011;5:192-202
38. Brunelin J, d'Amato T, van Os J, Cochet A, Suaud-Chagny MF, Saoud M. Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizophrenia, their unaffected siblings and controls. Schizophr Res. 2008;100:206-211
39. Brunelin J, d'Amato T, Van Os J, Costes N, Suaud Chagny MF, Saoud M. Increased left striatal dopamine transmission in unaffected siblings of schizophrenia patients in response to acute metabolic stress. Psychiatry Res. 2010;181:130-135
40. Hirvonen J, Hietala J. Dysfunctional brain networks and genetic risk for schizophrenia: Specific neurotransmitter systems. CNS Neurosci Ther. 2011;17:89-96
41. Walker E, Mittal V, Tessner K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu Rev Clin Psychol. 2008;4:189-216
42. Pryce CR, Feldon J. Long-term neurobehavioural impact of the postnatal environment in rats: Manipulations, effects and mediating mechanisms. Neurosci Biobehav Rev. 2003;27:57-71
43. Millstein RA, Holmes A. Effects of repeated maternal separation on anxiety- and depression-related phenotypes in different mouse strains. Neurosci Biobehav Rev. 2007;31:3-17